1887

Abstract

Japanese studies have defined the discrete 22092248 amino acid region of the non-structural 5A protein (NS5A) of hepatitis C virus genotype 1b (HCV 1b) isolates as the interferon sensitivity determining region (ISDR). European studies did not confirm these results since most of the ISDR sequences harboured an intermediate profile. Recently, a direct interaction between the NS5A protein, involving the ISDR, and the interferon-induced protein kinase (PKR) has been reported and presented as a possible explanation of HCV interferon resistance. In the present study, the entire NS5A amino acid sequence from 11 resistant and eight sensitive strains from European HCV 1b isolates was inferred from direct sequencing. The previously described important amino acid stretches and positions in NS5A were compared between the resistant and sensitive groups. Although some variations were observed, no clear differences could be directly correlated with the interferon sensitivity. However, sensitive strains were different, owing to more amino acid changes when compared to a consensus sequence from all strains. The carboxy- terminal region and especially the previously reported NS5A/V3 region showed most of the variations. Moreover, the conformational analysis of NS5A by secondary structure prediction allowed the differentiation of most sensitive strains from resistant ones. It was concluded that other regions different from ISDR were involved in resistance to interferon maybe via the interaction between NS5A and PKR.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-6-1373
1998-06-01
2022-12-09
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/6/9634077.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-6-1373&mimeType=html&fmt=ahah

References

  1. Asabe S. I., Tanji Y., Satoh S., Kaneko T., Kimura K., Shimotohno K. 1997; The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. Journal of Virology 71:790–796
    [Google Scholar]
  2. Bairoch A. 1993; The PROSITE dictionary of sites and patterns in proteins, its current status. Nucleic Acids Research 21:3097–3103
    [Google Scholar]
  3. Castelain S., Khorsi H., Zawadzki P., Sueur J. M., Capron J. P., Eb F., Duverlie G. 1997; Direct blotting electrophoresis for sequencing and genotyping hepatitis C virus. Journal of Virological Methods 65:237–243
    [Google Scholar]
  4. Chamberlain R. W., Adams N. J., Taylor L. A., Simmonds P., Elliott R. M. 1997; The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochemical and Biophysical Research Communications 236:44–49
    [Google Scholar]
  5. Chayama K., Tsubota A., Kobayashi M., Okamoto K., Hashimoto M., Miyano Y., Koike H., Kobayashi M., Koida I., Arase Y., Saitoh S., Suzuki Y., Murashima N., Ikeda K., Kumada H. 1997; Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745–749
    [Google Scholar]
  6. Chou P., Fasman G. D. 1978; Prediction of the secondary structure of proteins from their amino acid sequence. Advances in Enzymology 47:45–148
    [Google Scholar]
  7. Deleage G., Roux B. 1987; An algorithm for protein secondary structure prediction based on class prediction. Protein Engineering 1:289–294
    [Google Scholar]
  8. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. 1995; Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b - sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96:224–230
    [Google Scholar]
  9. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Ogura Y., Izumi N., Marumo F., Sato C. 1996; Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334:77–81
    [Google Scholar]
  10. Felsenstein J. 1993; PHYLIP: Phylogeny interference package, version 3.5c. Department of Genetics, University of Washington, Seattle, WA, USA:
    [Google Scholar]
  11. Gale M. J., Korth M. J., Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. 1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230217–227
    [Google Scholar]
  12. Geourjon C., Deleage G. 1995; ANTHEPROT 2.0: A threedimensional module fully coupled with protein sequence analysis methods. Journal of Molecular Graphics 13:209–212
    [Google Scholar]
  13. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. 1993; Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67:1385–1395
    [Google Scholar]
  14. Herion D., Hoofnagle J. H. 1997; The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 25:769–771
    [Google Scholar]
  15. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. 1991; Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences, USA 88:5547–5551
    [Google Scholar]
  16. Hofgartner W. T., Polyak S. J., Sullivan D. G., Carithers R. L., Gretch D. R. 1997; Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. Journal of Medical Virology 53:118–126
    [Google Scholar]
  17. Hoofnagle J. H., DiBisceglie A. M. 1997; Drug therapy: the treatment of chronic viral hepatitis. New England Journal of Medicine 336:347–356
    [Google Scholar]
  18. Ide Y., Zhang L. W., Chen M., Inchauspe G., Bahl C., Sasaguri Y., Padmanabhan R. 1996; Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182:203–211
    [Google Scholar]
  19. Inchauspe G., Zebedee S., Lee D. H., Sugitani M., Nasoff M., Prince A. M. 1991; Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proceedings of the National Academy of Sciences, USA 88:10292–10296
    [Google Scholar]
  20. Jakschies D., Zachoval R., Muller R., Manns M., Nolte K. U., Hochkeppel H. K., Horisberger M. A., Deicher H., Vonwussow P. 1994; Strong transient expression of the type I interferon induced MxA protein in hepatitis A but not in acute hepatitis B and hepatitis C. Hepatology 19:857–865
    [Google Scholar]
  21. Kaneko T., Tanji Y., Satoh S., Hijikata M., Asabe S., Kimura K., Shimotohno K. 1994; Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochemical and Biophysical Research Communications 205:320–326
    [Google Scholar]
  22. Kato N., Lan K. H., Ononita S. K., Shiratori Y., Omata M. 1997; Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. Journal of Virology 71:8856–8859
    [Google Scholar]
  23. Khorsi H., Castelain S., Wyseur A., Izopet J., Canva V., Rombout A., Capron D., Capron J. P., Lunel F., Stuyver L., Duverlie G. 1997; Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alfa therapy in French patients. Journal of Hepatology 27:72–77
    [Google Scholar]
  24. Kurosaki M., Enomoto N., Murakami T., Sakuma I., Asahina Y., Yamamoto C., Ikeda T., Tozuka S., Izumi N., Marumo F., Sato C. 1997; Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 25:750–753
    [Google Scholar]
  25. Maertens G., Stuyver L. 1997; Genotypes and genetic variation of hepatitis C virus. In The Molecular Medicine of Viral Hepatitis pp 183–233 Harrison T. J., Zuckerman A. J. Edited by James A., Morris A. In Molecular Medical Science Series Edited by Chichester: John Wiley;
    [Google Scholar]
  26. Major M. E., Feinstone S. M. 1997; The molecular virology of hepatitis C. Hepatology 25:1527–1538
    [Google Scholar]
  27. Markland W., Petrillo R. A., Fitzgibbon M., Fox T., McCarrick R., McQuaid T., Fulghum J. R., Chen W., Fleming M. A., Thomson J. A., Chambers S. P. 1997; Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae . Journal of General Virology 78:39–43
    [Google Scholar]
  28. Martinot-Peignoux M., Marcellin P., Pouteau M., Castelnau C., Boyer N., Poliquin M., Degott C., Descombes I., Lebreton V., Milotova V., Benhamou J. P., Erlinger S. 1995; Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050–1056
    [Google Scholar]
  29. Nakashima H., Nishikawa K., Ooi T. 1986; The folding type of a protein is relevant to the amino acid composition. Journal of Biochemistry (Tokyo) 99:153–162
    [Google Scholar]
  30. Reed K. E., Xu J., Rice C. M. 1997; Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A- associated kinase. Journal of Virology 71:7187–7197
    [Google Scholar]
  31. Smith D. B., McAllister J., Casino C., Simmonds P. 1997; Virus ‘quasispecies’: making a mountain outof a molehill?. Journal of General Virology 78:1511–1519
    [Google Scholar]
  32. Squadrito G., Leone F., Sartori M., Nalpas B., Berthelot P., Raimondo G., Pol S., Brechot C. 1997; Mutations in the nonstructural 5A region ofhepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113:567–572
    [Google Scholar]
  33. Tanimoto A., Ide Y., Arima N., Sasaguri Y., Padmanabhan R. 1997; The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochemical and Biophysical Research Communications 236:360–364
    [Google Scholar]
  34. Tanji Y., Kaneko T., Satoh S., Shimotohno K. 1995; Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. Journal of Virology 69:3980–3986
    [Google Scholar]
  35. Thompson J. D., Higgins D. G., Gibson T. J. 1994; CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Research 22:4673–4680
    [Google Scholar]
  36. Tong M. J., Elfarra N. S., Reikes A. R., Co R. L. 1995; Clinical outcomes after transfusion-associated hepatitis C. New England Journal of Medicine 332:1463–1466
    [Google Scholar]
  37. Zeuzem S., Lee J. H., Roth W. K. 1997; Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25:740–744
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-6-1373
Loading
/content/journal/jgv/10.1099/0022-1317-79-6-1373
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error